BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29850390)

  • 1. Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations.
    Emmanouil G; Ayiomamitis G; Zizi-Sermpetzoglou A; Tzardi M; Moursellas A; Voumvouraki A; Kouroumalis E
    Anal Cell Pathol (Amst); 2018; 2018():1616973. PubMed ID: 29850390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
    Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
    J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
    Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
    Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
    Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
    Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?
    Erdem H; Pay S; Musabak U; Simsek I; Dinc A; Pekel A; Sengul A
    Rheumatol Int; 2007 Aug; 27(10):969-73. PubMed ID: 17265155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
    De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
    Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
    Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
    World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
    Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
    Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers.
    Sawada T; Yashiro M; Sentani K; Oue N; Yasui W; Miyazaki K; Kai K; Fujita H; Nakamura K; Maeda K; Kakeji Y; Natsugoe S; Shirabe K; Nomura S; Shimada Y; Tomita N; Hirakawa K; Maehara Y
    Oncol Rep; 2013 Dec; 30(6):2609-16. PubMed ID: 24101199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.
    Oladipo O; Conlon S; O'Grady A; Purcell C; Wilson C; Maxwell PJ; Johnston PG; Stevenson M; Kay EW; Wilson RH; Waugh DJ
    Br J Cancer; 2011 Feb; 104(3):480-7. PubMed ID: 21285972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features.
    Lam AK; Ong K; Ho YH
    Int J Colorectal Dis; 2008 Jun; 23(6):587-94. PubMed ID: 18322660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC‑8 stratification.
    Tong G; Zhang G; Liu J; Zheng Z; Chen Y; Niu P; Xu X
    Oncol Rep; 2020 Apr; 43(4):1187-1198. PubMed ID: 32323802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer.
    Zhang J; Tao J; Gao RN; Wei ZY; He YS; Ren CY; Li QC; Liu YS; Wang KW; Yang G; Qian C; Chen JH
    Front Immunol; 2021; 12():715559. PubMed ID: 34539647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.